• The Role of Whole Blood and Massive Transfusion (Archived March 24, 2016 Session)

    Category: Shock
    John Hess, MD, Alan Murdock, MD and Phillip Spinella, MD
    CME 1 CME Credit(s)

    In accordance with the ACCME Accreditation Criteria, the American College of Surgeons, as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. Therefore, it is mandatory that both the program planning committee and speakers complete disclosure forms. Members of the program committee were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. The ACCME defines a ‘commercial interest’ as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients”.  It does not consider providers of clinical service directly to patients to be commercial interests.  The ACCME considers “relevant” financial relationships as financial transactions (in any amount) that may create a conflict of interest and occur within the 12 months preceding the time that the individual is being asked to assume a role controlling content of the educational activity.

    ACS is also required, through our joint sponsorship partners, to manage any reported conflict and eliminate the potential for bias during the activity.  All program committee members and speakers were contacted and the conflicts listed below have been managed to our satisfaction.  However, if you perceive a bias during a session, please report the circumstances on the session evaluation form.  

    Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage. 

    The requirement for disclosure is not intended to imply any impropriety of such relationships, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the presentation.


    Presenter: Alan Murdock, MD, Allegheny Health Network Medical Education Consortium, Pittsburgh, PA – Nothing to Disclose

    John Hess, MD, University of Washington, Seattle, WA – Discloses Author Royalties from UpToDate and Royalties from the US Government and University of Maryland

    Phillip Spinella, MD, Washington University in St. Louis, St. Louis, MO – Discloses Consulting fees to TerumoBCT

    Moderator: Warren Dorlac, MD, University of Colorado Health, Loveland, CO - Nothing to Disclose

    Planning Committee: Stephen Barnes, MD; Lena Napolitano, MD; Peter Rhee, MD; Scott Sagraves, MD; Lynette Scherer, MD; Martin Schreiber, MD; Mark Seamon, MD; Nicole Stassen, MD; Carlos Brown, MD; Tomas Jacome, MD; Randeep Jawa, MD; Matthew Martin, MD; Susan Rowell, MD; Susan Steinemann, MD – Nothing to Disclose

    1 Credit(s) Access This Course